Digital Health Workbench synthesizes PubMed, ClinicalTrials.gov, and FDA guidance into structured, citation-ready deliverables — in minutes, not days. Built for anyone doing serious digital health research: academic researchers, medical and scientific writers, health policy and HTA analysts, science journalists, medical librarians, and pharma Digital Health teams alike.
PubMed, ClinicalTrials.gov, FDA guidance, vendor databases, competitor press releases. No single place to query all of them.
A landscape assessment that should take an afternoon takes three days of searching, synthesizing, and formatting.
Every analyst reinvents the same research. Prior assessments live in email threads and personal folders — invisible to the rest of the team.
Choose your deliverable type and describe what you need in plain language.
Workbench simultaneously queries PubMed, ClinicalTrials.gov, and FDA guidance documents, filtering for relevance.
GPT-4o synthesizes findings into a formatted, cited intelligence document ready to share with your team.
Describe your research question in plain language. Workbench matches it to the right deliverable format — click a query to see what it generates.
More formats — including Vendor Comparison and Competitive Intelligence — are on the roadmap.
35M+ biomedical articles via NCBI E-utilities
500K+ registered clinical studies
Real-time guidance document monitoring via FDA's Digital Health Center of Excellence
Recent advancements in digital health technologies have introduced novel endpoints for measuring cancer-related fatigue (CRF) in oncology trials. Current activity is characterized by a focus on wearable devices and digital biomarkers, with few trials explicitly focusing on CRF. The regulatory environment is not yet fully aligned with rapid technological advancements, presenting both challenges and opportunities for innovation [PMID:40707827].
The measurement of cancer-related fatigue in oncology trials is increasingly incorporating digital endpoints, primarily through wearable devices...
Given moderate validation strength and limited multi-site data, a pilot deployment in a single Phase 2 cohort is recommended before broader rollout...
Program teams evaluating decentralized trial designs should account for evolving DDT qualification pathways...
Currently available by invitation. Request access to evaluate Digital Health Workbench for your work.